article

European Pharmaceutical Review Issue 1 2021

Posted: 15 February 2021 | | No comments yet

In this issue we discuss whether clinicians know enough about the development of biosimilars to buy in, explore the biggest M&A trends in pharma and what to expect this year and consider the importance of disaccharides in the stabilisation of biologics. The journal also features articles on the fundamentals of contemporary supply chain management and how COVID-19 has impacted oncology drug development.

Also in issue 1:

  • FORMULATION, DEVELOPMENT & DELIVERY
    Promising biocompatible and biodegradable drug nanocarriers for cancer treatment and bone defect repair
    Ying-Jie Zhu, Chinese Academy of Sciences, and Tsun-Kong Sham, University of Western Ontario
  • MANUFACTURING, PACKAGING & LOGISTICS
    Regulatory challenges and myths in pharmaceutical 3D printing
    Prachi Khamkar and Atul Kadam, Shree Santkrupa College of Pharmacy
  • BIOPROCESSING & BIOPRODUCTION
    Manufacturing of CAR T-cell therapies
    Maciej Nakoniecznik, University College London
  • METABOLOMICS
    Microbiome therapeutic development boosted by metabolomics
    Christopher Ford, Seres Therapeutics
  • QA/QC & ANALYTICAL TECHNIQUES
    Effect of moisture variation on the robustness of NIR spectroscopy-based calibration models
    Derya Cebeci, PortMera Corp
    Established and new mass spectrometry applications to drug discovery and development
    Ioannis Papayannopoulos, Celldex Therapeutics
  • BREXIT
    New regulatory landscape for biosimilars in the UK and EU post Brexit transition period
    Marie Manley and Chris Boyle, Sidley Austin

The rest of this content is restricted - login or subscribe free to access

EPR Issue #2 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend